American Society for Reproductive Medicine

Medical professional society

Based in DC

🤖

AI Overview

With $190K in lobbying spend across 11 quarterly filings, American Society for Reproductive Medicine is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2023 to 2025.

$190K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$20K
2024$90K
2025$80K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Defense, Veterans, Taxation, Budget/Appropriations

  • Issues related to TRICARE coverage for assisted reproductive technology (ART) in the Fiscal Year 2024 (FY24) National Defense Authorization Act (NDAA)
  • Issues related to TRICARE coverage for assisted reproductive technology (ART) in H.R. 2670/S. 2226, the Fiscal Year 2024 (FY24) National Defense Authorization Act (NDAA)
  • General issues related to access to infertility treatment and care and specific issues related to TRICARE coverage for assisted reproductive technology (ART) in H.R. 2670/S. 2226, the National Defense

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.